TrialBlood2012

Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.

Issa F Khouri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.